Fermentation is no longer the quiet corner of biotechnology—it is the industrial heart of biological manufacturing. From therapeutic enzymes and recombinant proteins to plasmid DNA, probiotics, and metabolites, the Fermentation CDMO has evolved from a service provider into the biological architect of precision, speed, and reproducibility. Modern programs live or die by the sophistication of […]
Tag: Microbial platforms
The Evolution of HPAPI Manufacturing for CDMOs
HPAPIs are the new center of gravity.Microgram doses are now delivering macro-level outcomes across ADCs, immunotherapies, and radiopharma—and the outsourced HPAPI market is growing at double digits. The winners? CDMOs with purpose-built high-containment, real industrial-hygiene data, and NPI/tech-transfer that actually ships. This isn’t “more GMP”—it’s QbD fused to exposure control, picogram-level cleaning limits, and multilayer […]
13 Contamination Traps in Animal Health CDMO—Catch Them Before They Bite
13 Contamination Traps in Animal Health CDMO – Introduction Contamination doesn’t announce itself; it drifts in as a “minor deviation” and leaves you with failed release, blown timelines, or a recall. Animal health programs are uniquely exposed: probiotics and sterile injectables under one roof, waterline dosing in barns and hatcheries, larger IV bags, and species […]
10 ADC CDMO Decisions That Make or Break
Intro Summary: Your antibody–drug conjugate program is walking a tightrope between power and buildability; the ADC CDMO you choose is the safety net—or the wind gust. Ten decisions separate clean, on-schedule INDs from costly do-overs, each tied to capabilities a world-class ADC & Bioconjugate CDMO must show: precise drug placement (site-specific conjugation), true OEB-5 HPAPI […]
The Top 10 Capabilities Every Plasmid DNA CDMO Must Have
Introduction: Why Plasmid DNA Remains Foundational In 2025, the global cell and gene therapy market is booming, and at the heart of nearly every program lies plasmid DNA. Whether you are manufacturing mRNA vaccines, producing viral vectors for gene therapy, or engineering advanced microbial systems, plasmid DNA is the molecular blueprint that makes innovation possible. […]
Streptomyces coelicolor: A Filamentous Chassis for Antibiotics, Enzymes, and Synthetic Biology
As the demand for next-generation natural products, precision biosynthesis, and novel antibiotics rises, the limitations of conventional microbial hosts become more apparent. While E. coli and Bacillus excel in protein expression, they fall short in handling large, complex biosynthetic gene clusters (BGCs) or producing high-value secondary metabolites. Enter Streptomyces coelicolor—a soil-dwelling actinomycete with extraordinary genetic […]
Advancements in Fungi Strain Fermentation
The fungi strain fermentation market has witnessed substantial innovation in recent years, driven by the increasing demand for sustainable and efficient biotechnological solutions across various industries. These advancements have not only enhanced the yield and efficiency of fungal fermentation processes but also broadened the application spectrum in pharmaceuticals, agriculture, and biofuel production. Here, we explore […]